A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC
Clinical trial NCT04286958 · UNKNOWN
Trial details
- NCT number
- NCT04286958
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2022-12-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.